Last $27.01 USD
Change Today +0.47 / 1.77%
Volume 163.1K
MDCO On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 10:56 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven R. Steinhubl M.D., FACC

Global Vice President of Thrombosis, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 3 different industries.

See Board Relationships
55--

Background*

Dr. Steven R. Steinhubl, M.D., FACC has been Global Vice President of Thrombosis of Medicines Co. since February 2008. Dr. Steinhubl is responsible for the development programs for both cangrelor, an investigational antiplatelet agent, and Angiox(R) (bivalirudin) from the European headquarters in Zurich, Switzerland. Dr. Steinhubl joined Medicines Co. as Global Vice President, of Thrombosis. Dr. Steinhubl is a director of digital medicine at the Scripps Translational ...

Read Full Background

Corporate Headquarters*

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships*

2014-Present
Chairman

Education*

BS
Purdue University
MS
Georgetown University
Unknown/Other Education 1988
St Louis University School Of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $27.01 USD +0.47

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James Patrick Mackin Chief Executive Officer, President and Director
CryoLife Inc.
--
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Albert D. Friesen Ph.D.Founder, Chairman and Chief Executive Officer
Medicure Inc.
--
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.